(Q47988711)

7 February 2018

title

Clinical research in chronic obstructive pulmonary disease: needs and opportunities. (English)

1 reference

7 February 2018

chronic obstructive pulmonary disease

main subject

1 reference

4

1 reference

7 February 2018

author name string

Thomas L Croxton

1

1 reference

7 February 2018

Gail G Weinmann

2

1 reference

7 February 2018

Robert M Senior

3

1 reference

7 February 2018

James D Crapo

5

1 reference

7 February 2018

A Sonia Buist

6

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 April 2003

1 reference

7 February 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

7 February 2018

volume

167

1 reference

7 February 2018

page(s)

1142-1149

1 reference

7 February 2018

issue

8

1 reference

7 February 2018

Pulmonary rehabilitation in patients with COPD.

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Smoking and lung function of Lung Health Study participants after 11 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Effect of theophylline on exercise performance in patients with severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Long-term health status and quality of life outcomes of lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

A 30-year perspective on alpha 1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Matrix metalloproteinases. Matrix degradation and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Fibulin-5/DANCE is essential for elastogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Mechanisms in COPD: differences from asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Role of latent viral infections in chronic obstructive pulmonary disease and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Oxidants/antioxidants and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Exhaled markers of pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Inhibition of VEGF receptors causes lung cell apoptosis and emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

A pilot study of all-trans-retinoic acid for the treatment of human emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Adding spirometry, carbon monoxide, and pulmonary symptom results to smoking cessation counseling: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Smoking cessation in primary care clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Oxidative stress and lung inflammation in airways disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Health status measurement in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Clinical practice. Acute exacerbations of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Nutritional support for individuals with COPD: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

21 January 2018

Impact of sleep in COPD.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Breathing during sleep in patients with obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Lobar volume reduction surgery: a method of increasing the lung cancer resection rate in patients with emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

The prevalence of COPD: using smoking rates to estimate disease frequency in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

Short-term and Long-term Outcomes After Bilateral Lung Volume Reduction Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200207-756WS

10.1164/RCCM.200207-756WS

21 January 2018

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

12684252

1 reference

7 February 2018